Caplin Point selected under Forbes Asia’s ‘200 best under billion list’

22 Aug 2022 Evaluate

Caplin Point Laboratories has been selected under Forbes Asia’s 200 Best Under a Billion list for 2022. Forbes Asia has selected 200 best performing companies, with revenues of less than a billion, from a list of over 17,000 public listed companies across the Asia-Pacific.

Caplin Point has also been ranked 1 in India for “Most Consistent Profitable Growth across last 10 years” by Value Research magazine in the Wealth Insight June 2022 issue.

Caplin Point Laboratories is engaged mainly in manufacturing a wide range of Ointments, Creams and other External application preparations in addition to the regular segments of pharmaceutical formulations.

Caplin Point Lab Share Price

1841.20 53.85 (3.01%)
31-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.75
Dr. Reddys Lab 1271.05
Cipla 1510.90
Zydus Lifesciences 914.65
Lupin 2112.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×